Skip to main content

Lupus (Systemic Lupus Erythematosus) and cannabis in West Virginia

The state currently does not list this condition as qualifying, and the program does not provide open-ended physician discretion to add conditions. Verify with the state regulator, because programs change.

Not on the qualifying list
✗ No
LEGAL
30-day supply as certif…
POSSESSION
$50/yr
STATE FEE
14–45 d
TIMELINE
Not on the qualifying list. The state currently does not list this condition as qualifying, and the program does not provide open-ended physician discretion to add conditions. Verify with the state regulator, because programs change.

West Virginia statute and program

The West Virginia Medical Cannabis Program is the operating authority for West Virginia patient certification. The authoritative legal text is: West Virginia Code Chapter 16A: Medical Cannabis Act. The program portal is at West Virginia Medical Cannabis Program.

What the evidence says about cannabis and Lupus (Systemic Lupus Erythematosus)

Systemic lupus erythematosus (SLE), commonly called lupus, is a chronic autoimmune disease in which the immune system produces autoantibodies that attack the body's own tissues. Inflammation can affect joints, skin, kidneys, blood, lungs, heart, and the nervous system. Lupus is a relapsing-remitting disease — patients experience flares and periods of relative quiescence.

For the full evidence base, including the NASEM tier, randomized trial summaries, and symptom-domain breakdown, read the mmjnow Lupus (Systemic Lupus Erythematosus) page.

How to qualify in West Virginia

The West Virginia Medical Cannabis Program requires the following registration steps for a Lupus (Systemic Lupus Erythematosus) patient (or any qualifying diagnosis):

  1. See a West Virginia-registered medical cannabis physician. Under the West Virginia Medical Cannabis Act (W. Va. Code §16A-1-1 et seq.), a West Virginia-licensed physician who has completed the West Virginia Bureau for Public Health four-hour training course and registered with the West Virginia Office of Medical Cannabis (OMC) must certify the patient. Qualifying conditions include cancer, HIV/AIDS, ALS, Parkinson’s, MS, intractable seizures, sickle-cell anemia, intractable pain, terminal illness, Crohn’s, neuropathies, Huntington’s, PTSD, and severe chronic or intractable pain (§16A-4-3).
  2. Apply through the West Virginia OMC online portal. The patient creates an account in the OMC online registry, uploads a West Virginia driver license or state ID and a passport-style photo, and links the physician’s electronic certification. Caregivers (required for minor patients) register separately and undergo a state and federal criminal background check.
  3. Pay the $50 state registration fee (or qualify for a waiver). The annual West Virginia OMC patient identification card fee is $50, waived for veterans, patients enrolled in the federal Supplemental Nutrition Assistance Program (SNAP), and patients with documented financial hardship under OMC rules. Caregiver registration is also $50 with the same waiver eligibility.
  4. Receive the card and purchase from a West Virginia dispensary. West Virginia OMC patient identification cards are issued within roughly 30 days of complete application. Patients may purchase up to a 30-day supply (forms include pills, oils, topical applications, tinctures, liquids, and dermal patches — no smokable flower under §16A-4-3) from any licensed West Virginia medical cannabis dispensary. West Virginia does not honor out-of-state medical cards.
State registration fee
$50
Physician visit (typical)
$150–$300
Certification to card
14–45 days
Out-of-state patients
Not eligible
Minors
Eligible with caregiver

For full West Virginia registration steps, fees, and reciprocity rules, see the West Virginia cannabis-laws page.

ICD-10 code

A certifying physician documenting Lupus (Systemic Lupus Erythematosus) for the West Virginia medical cannabis program will typically record ICD-10 M32.9 or SNOMED-CT 55464009 in the patient's record. The state registry does not itself collect ICD-10 codes in most programs, but the physician's chart is the audit trail if the certification is later reviewed.

Frequently asked questions

Does West Virginia list Lupus (Systemic Lupus Erythematosus) as a qualifying condition for medical cannabis?

No. West Virginia's qualifying-condition list does not currently include Lupus (Systemic Lupus Erythematosus), and the state's program does not give physicians open-ended discretion to add conditions outside the list. Patients with Lupus (Systemic Lupus Erythematosus) in West Virginia have limited in-state pathways under the medical program as written. Options to verify and pursue include: petitioning the state regulator to add the condition (where the statute permits public petitions); consulting a physician about whether a co-occurring listed condition could support certification; or reviewing whether the state's program is undergoing legislative expansion. West Virginia program rules change, so verify the current list with the regulator before drawing a final conclusion.

How do I get a West Virginia medical marijuana card for Lupus (Systemic Lupus Erythematosus)?

Because West Virginia does not currently list Lupus (Systemic Lupus Erythematosus) as a qualifying condition, a card for Lupus (Systemic Lupus Erythematosus) alone may not be obtainable in-state under the program rules as written. Step one is finding a physician licensed in West Virginia who is registered with West Virginia Medical Cannabis Program and willing to evaluate Lupus (Systemic Lupus Erythematosus) cases. Step two is collecting your records (diagnosis documentation, treatment history, and the ICD-10 code your physician will use) and bringing them to the certification visit. Step three is the physician's certification through the state registry, followed by the patient registration application, state fee, and waiting period before the card is issued. West Virginia does not honor out-of-state cards, so the certification process has to originate inside the state. Verify the patient minimum age with the state program before applying. The authoritative source for the current process is the West Virginia Medical Cannabis Program site at https://omc.wv.gov/; the state updates fees, forms, and physician registration rules periodically.

What does the evidence say about cannabis for Lupus (Systemic Lupus Erythematosus)?

For Lupus (Systemic Lupus Erythematosus), evidence is described as limited (a small number of supportive studies, often underpowered or focused on narrow symptom domains). The mmjnow condition page for Lupus (Systemic Lupus Erythematosus) lays out the current evidence base, including the citations underlying that evidence tier — typically the National Academies of Sciences, Engineering, and Medicine consensus reports, federal agency guidance, and peer-reviewed reviews. Evidence quality is independent of state law: a state can list a condition for which evidence is limited, and a state can decline to list a condition for which evidence is strong. Patients deciding whether to pursue medical cannabis for Lupus (Systemic Lupus Erythematosus) should review the underlying evidence (linked on the condition page) and discuss expected benefit, dosing, and risk with a clinician familiar with both Lupus (Systemic Lupus Erythematosus) and cannabinoid pharmacology. Cannabis is not a substitute for evidence-based first-line treatments for Lupus (Systemic Lupus Erythematosus); the evidence position above describes whether trial data supports its use, not whether it should replace standard care.

Sources

  1. West Virginia Code Chapter 16A: Medical Cannabis Actaccessed May 16, 2026
  2. West Virginia Office of Medical Cannabis (Bureau for Public Health)accessed May 16, 2026
  3. Wikipedia: Cannabis in West Virginiaaccessed May 16, 2026
  4. NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases: Lupusaccessed May 18, 2026
  5. NASEM: The Health Effects of Cannabis and Cannabinoids (2017)accessed May 18, 2026

    “Substantial evidence that cannabis or cannabinoids are effective for chronic pain in adults.”

  6. Lupus Foundation of America: Marijuana and Lupusaccessed May 18, 2026
  7. American College of Rheumatology: 2023 Guideline for SLE Management (executive summary)accessed May 18, 2026
  8. MedlinePlus: Systemic lupus erythematosusaccessed May 18, 2026